A recent study indicates that patients who discontinue popular weight-loss injections like Wegovy and Mounjaro tend to recover lost weight at a significantly accelerated pace than those who stop conventional lifestyle plans.
Findings released in a prominent medical journal demonstrates that while obese individuals frequently drop a large proportion of their total mass while undergoing treatment, the weight comes back at an estimated rate of 0.8 kg per month after stopping.
"Individuals purchasing these treatments should be informed of the danger of rapid weight regain when the treatment ends," cautioned lead investigator Dr. Susan Jebb.
Such speed of recovery means a return to starting mass in about one and a half years.
Weighing Therapies
The research, which looked at dozens of studies involving thousands of patients, contrasted the results of GLP-1 agonists with other pills.
The team note that individuals who shed pounds through dieting usually see a more gradual creep back—around 0.1 kg a month—after stopping.
The Reason for the Quick Regain
Nutrition scientists believe the mechanism of the jabs is key to understanding the accelerated regain.
These medications imitate a body's own chemical called glucagon-like peptide-1, which moderates hunger.
"Long-term administration of the hormone levels several times higher than normal could lead to the system to produce less of its own natural GLP-1, and may also reduce responsiveness to its effects," explained Dr. Adam Collins, a dietetics expert.
"Discontinuation of this GLP-1 'fix' leads to appetite is no longer kept in check, making overeating a significant risk."
An Ongoing Issue?
The NHS recommend the jabs for people with weight-linked health risks, accompanied by prescribed lifestyle changes.
Many experts contend that, considering the significant potential of relapse, the therapy should be considered long-term.
This perspective is echoed by pharmaceutical companies, who state that the findings "emphasize the persistent nature of obesity," akin to managing conditions like diabetes.
User Testimonies
Users who have stopped the jabs report a sudden resurgence of hunger.
"It was like something that goes on and I was suddenly starving," described one woman.
This difficulty is compounded if users have not established sustainable dietary or behavioural modifications during treatment.
Growing Interest
Figures indicate that a significant number of adults in the UK have used these injections in the past year, with desire being substantial.
- Use is more common among females compared to males.
- The middle-aged age group shows the highest usage rates.
- Many access the drugs through private prescriptions rather than the NHS.
Ultimately, experts emphasize that while these medications are potent tools for shedding pounds, they are not a magic solution and lasting health benefits likely depends on combined behavioural management.
